Contents
Introduction
Why is everyone searching for Matthew Schissler? As a private investor, entrepreneur, and founder of Cord Blood America, Schissler has built a diversified wealth portfolio that spans biotech, private equity, and emerging franchises. Yet unlike flashy billionaires, he operates largely outside the public spotlight—making his net worth a topic of growing curiosity.
For 2026, financial estimates place Matthew Schissler’s net worth in the range of 8 million to 15 million. This range reflects his business equity, long-term investment holdings, and advisory roles. It is important to note that as a private individual, no exact public figure exists; these estimates derive from company filings, known stakes, and comparable private investor models.
Schissler’s wealth is driven primarily by three engines: founding and leading Cord Blood America, managing concentrated private investments through Pyrenees Investments LLC, and income from board/advisory positions across small-cap and mid-cap firms.
In this article, you will learn his estimated net worth, a detailed breakdown of assets and income, the businesses that built his fortune, his investment strategy, financial growth timeline, lifestyle, and answers to frequently asked questions.
Matthew Schissler Net Worth in 2026
As of 2026, Matthew Schissler’s estimated net worth falls between 8 million and 15 million. This range is based on public business filings, known equity stakes in Cord Blood America (CBAI) and other ventures, plus typical valuations for private investment portfolios. Disclaimer: Because Schissler is a private investor and not a publicly traded CEO with mandatory wealth disclosures, no exact net worth figure is available. All estimates are derived from available data and comparable industry analysis.
Compared to previous years, Schissler’s wealth has likely grown modestly but steadily. In 2020, estimates placed his net worth near $5–8 million. The increase reflects the maturation of his private investment holdings, continued income from advisory roles, and the underlying value of businesses he founded or backed—particularly in biotech infrastructure and niche franchises.
Where does he stand among similar entrepreneurs? Schissler occupies a realistic upper-mid tier: wealthier than early-stage angel investors or small business owners, but far below billionaire founders. He is comparable to serial entrepreneurs who launched one publicly traded small-cap company (Cord Blood America) and now manage a family-office-style investment firm. Think of founders of regional biotech firms or successful franchise owners who later pivoted to private equity—wealthy, but not household names.
In essence, Schissler represents the “quiet millionaire” archetype: wealth built through business creation, patient investing, and diversification, rather than a single massive exit.
Net Worth Breakdown
Matthew Schissler’s estimated $8–15 million net worth is distributed across four primary components. Below is a realistic breakdown based on typical private investor portfolios and his known business activities.
- Business Equity (35–45%) – This includes his founding stake in Cord Blood America (CBAI) and any remaining equity after dilution, plus ownership in Pyrenees Investments LLC and other active ventures like Rainmakers International. These holdings represent the core of his wealth.
- Private Investments (30–40%) – Through GHS Investments and personal accounts, Schissler holds concentrated positions in small-cap and mid-cap companies. These are long-term value investments, often illiquid but appreciating over time.
- Advisory/Board Roles (10–15%) – Schissler serves on boards (e.g., IIOT-OXYS, Inc.) and provides strategic advisory services. Compensation typically includes cash retainers, stock options, or equity grants.
- Other Income Streams (5–10%) – This includes past salaries, consulting fees, and potentially returns from franchise or fitness-related ventures such as Work Your Core Investments.
| Component | Estimated % of Net Worth | Key Sources |
|---|---|---|
| Business Equity | 35–45% | Cord Blood America, Pyrenees Investments, Rainmakers International |
| Private Investments | 30–40% | GHS Investments, small/mid-cap stock portfolio |
| Advisory/Board Roles | 10–15% | IIOT-OXYS board seats, consulting agreements |
| Other Income Streams | 5–10% | Past salaries, franchise/fitness ventures |
This balanced allocation highlights Schissler’s preference for ownership and long-term value over active trading or speculative bets.
Business Ventures That Built His Wealth
Matthew Schissler’s wealth did not come from a single windfall but from systematically building and scaling multiple businesses across different sectors. Three ventures stand out as primary wealth drivers.
Cord Blood America (CBAI) – Founded in 2003, this is Schissler’s most recognized company. The firm specialized in the collection, storage, and preservation of umbilical cord blood stem cells—a growing field in regenerative medicine. As founder and leader, Schissler navigated the company through public listing (OTC markets), international expansion into Germany, Argentina, and parts of Asia, and multiple rounds of financing. How it contributed to wealth: While CBAI never became a giant, Schissler retained significant equity through its growth years. He likely monetized portions through secondary sales or distributions, and the venture established his credibility as a public company founder—opening doors to later investments and board seats. Even today, residual value from CBAI remains part of his business equity.
Work Your Core Investments – This represents Schissler’s pivot into the fitness and franchise sector. Though details are less public, “Work Your Core” appears to be an investment vehicle focused on boutique fitness concepts or franchise operations. Fitness franchises (e.g., core-strengthening studios, boutique gyms) have seen strong recurring revenue models. For Schissler, this expansion diversified him away from pure biotech into consumer services. Franchise ownership typically generates cash flow through royalties or equity in operating units, adding a stable income stream to complement his more volatile small-cap investments.
Other Ventures (Aviation & Advisory) – Schissler has also been linked to aviation-related investments, though specifics remain private. These likely involve fractional ownership or leasing arrangements—common among investors seeking asset diversification and tax advantages. Additionally, his advisory roles (e.g., IIOT-OXYS, Inc.) provide both cash compensation and equity upside. Earlier ventures like Rainmakers International (advertising/marketing) and Feel Golf Co., Inc. (sports equipment) contributed experience and modest returns, but were not major wealth builders.
In summary, Cord Blood America laid the foundation, Work Your Core Investments broadened his cash flow base, and a mix of advisory roles and niche holdings rounded out his portfolio.
Investment Strategy & Income Sources
Matthew Schissler does not build wealth through short-term trading or flashy exits. Instead, his approach mirrors that of a private family office: patient, concentrated, and compounding over years. Understanding his investment strategy explains how his net worth continues to grow steadily.
Private Equity Focus – Through vehicles like Pyrenees Investments LLC and GHS Investments, Schissler deploys capital into private companies, often at early or growth stages. Unlike venture capitalists chasing unicorns, he targets businesses with proven models but limited access to public markets. This allows him to buy equity at reasonable valuations and hold until maturity.
Small & Mid-Cap Investments – Schissler is known to favor small-cap and mid-cap public companies. These are often overlooked by institutional investors, creating mispricing opportunities. His board role at IIOT-OXYS, Inc. (a small-cap industrial IoT firm) exemplifies this: he takes concentrated stakes where he can add strategic value, not merely speculate.
Long-Term Value Investing – Following principles similar to Warren Buffett or Peter Lynch, Schissler buys businesses—not tickers. He looks for durable competitive advantages, competent management, and room for growth. Holding periods typically span years, not quarters. This reduces transaction costs and tax drag while allowing compounding to work.
Diversification Approach – Schissler diversifies across sectors (biotech, fitness, aviation, industrials), asset types (business equity, private investments, board compensation), and illiquidity profiles (some holdings trade publicly, others are locked up). However, he avoids over-diversification—his portfolio remains concentrated enough to generate meaningful returns.
How This Builds Wealth Continuously – Each component feeds the next: board roles provide cash and options; options convert into equity; equity generates capital gains; gains are redeployed into new private investments. Meanwhile, franchise-related cash flow (Work Your Core) funds living expenses, allowing his investment portfolio to remain untouched and fully compounded. This virtuous cycle—earn, invest, hold, repeat—is the engine behind his sustained net worth growth.
Career Timeline & Financial Growth
Matthew Schissler’s journey from biology graduate to multi-millionaire investor followed a deliberate, step-by-step path. Below is a timeline of key milestones that shaped his financial growth.
Early Career (Late 1990s – 2002): Schissler earned a B.A. in Biology and Public Policy from St. Mary’s College of Maryland. He initially worked in scientific or policy-related roles, though specific positions are not publicly detailed. This foundation later proved valuable when he entered the biotech sector.
Major Turning Point – Founding Cord Blood America (2003): At age 20-something, Schissler founded Cord Blood America, Inc. This was his entrepreneurial launchpad. The company grew from a startup to an OTC-traded public entity, expanding internationally to Germany, Argentina, and parts of Asia. This venture generated his first significant equity value.
Expansion & Diversification (2008–2015): Schissler took on leadership roles in other sectors: Rainmakers International (advertising) and Feel Golf Co., Inc. (sports equipment). While not billion-dollar successes, these ventures honed his management skills and broadened his network. Financial growth during this period was steady but not explosive.
Shift to Investor (2016–Present): Recognizing the power of ownership without daily operations, Schissler pivoted to private investing. He founded Pyrenees Investments LLC and GHS Investments, focusing on long-term value in small and mid-cap companies. He also accepted board and advisory roles (e.g., IIOT-OXYS, Inc.) and launched franchise/fitness investments via Work Your Core Investments.
| Period | Milestone | Financial Impact |
|---|---|---|
| ~2000–2002 | Biology degree & early jobs | Minimal capital |
| 2003 | Founded Cord Blood America | Created core equity |
| 2008–2015 | Diversified into advertising, golf | Steady income, network growth |
| 2016–2026 | Shift to private equity, board roles | Compounding wealth, $8–15M range |
This timeline shows a clear arc: from founder to diversified investor, with each phase building on the last.
Net Worth Growth Over Time
Tracking Matthew Schissler’s net worth year-by-year requires estimation, as he is a private investor. However, based on business milestones and typical small-cap company performance, the following trajectory is plausible.
Key Jumps Explained:
- 2003–2008 (Founding to Peak CBAI): Initial wealth creation from Cord Blood America equity as the company expanded internationally.
- 2010–2014 (Public Listing & Stabilization): CBAI traded on OTC markets; Schissler likely took some profits or saw valuation growth.
- 2016–2020 (Shift to Private Equity): Launch of Pyrenees Investments and GHS Investments; board roles added income and equity grants.
- 2021–2026 (Franchise & Fitness Expansion): Work Your Core Investments generated cash flow; small-cap portfolio appreciated with market cycles.
Below is a simplified estimated growth table (figures in millions USD):
| Year | Estimated Net Worth | Notable Event |
|---|---|---|
| 2010 | $2–4M | CBAI publicly traded |
| 2014 | $3–5M | Diversification into other ventures |
| 2018 | $4–7M | Shift to private equity investing |
| 2020 | $5–8M | Began fitness/franchise investments |
| 2022 | $6–10M | Board roles & advisory income |
| 2024 | $7–12M | Portfolio appreciation |
| 2026 | $8–15M | Compounded growth from all streams |
The upward trend reflects Schissler’s patient, long-term approach—no single astronomical exit, but consistent compounding.
Assets, Lifestyle & Financial Habits
Business Holdings – Schissler’s primary assets are illiquid business holdings: equity in Cord Blood America (residual), ownership of Pyrenees Investments LLC and GHS Investments, board-related stock options in IIOT-OXYS, Inc., and franchise interests through Work Your Core Investments. Unlike celebrities, he does not publicly list luxury real estate or exotic car collections.
Lifestyle Indicators – Available public records suggest a comfortable but not extravagant lifestyle. Schissler appears to live well below the means typical of a $10M net worth individual. No private jets, mansion purchases, or flashy social media displays are documented. His coaching work in youth baseball and soccer further suggests a grounded, community-oriented personal life.
Financial Discipline – Schissler exemplifies reinvestment over consumption. Rather than cashing out after Cord Blood America, he rolled capital into new private investments. He holds board seats for equity grants rather than high cash salaries. His franchise ventures likely cover living expenses, allowing his investment portfolio to compound untouched. This discipline—delaying gratification, avoiding debt-fueled lifestyle inflation—is the quiet engine behind his sustained net worth growth.
FAQs
What is Matthew Schissler’s net worth?
Matthew Schissler’s estimated net worth in 2026 8 million to 15 million. As a private investor and entrepreneur, no exact public figure exists. This range is based on his business equity, private investments, and board advisory roles.
How does he make money?
Schissler makes money through four primary channels:
(1) Business equity from companies he founded (e.g., Cord Blood America)
(2) Private investment returns from small and mid-cap holdings via Pyrenees Investments and GHS Investments
(3) Compensation from board and advisory roles
(4) Cash flow from franchise and fitness ventures like Work Your Core Investments
What companies does he own?
He founded Cord Blood America, Inc. and owns or manages Pyrenees Investments LLC and GHS Investments. He also holds equity in IIOT-OXYS, Inc. (board seat), Rainmakers International, and franchise/fitness interests through Work Your Core Investments. Earlier ventures include Feel Golf Co., Inc.
Is he a billionaire?
No. Matthew Schissler is not a billionaire. His estimated net worth of $8–15 million places him in the upper-mid tier of entrepreneurs and private investors. Unlike biotech or tech founders who achieved billion-dollar exits, Schissler built wealth through steady, diversified business and investment activities.
What does he do now?
Currently, Schissler focuses on managing his private investment portfolios (Pyrenees Investments, GHS Investments), serving on corporate boards (including IIOT-OXYS, Inc.), and expanding his fitness and franchise ventures. He also remains active as a youth baseball and soccer coach, emphasizing character development and discipline.
Conclusion
Matthew Schissler’s estimated $8–15 million net worth is the product of patient entrepreneurship, disciplined investing, and strategic diversification. His wealth drivers—Cord Blood America, private investments through Pyrenees and GHS Investments, board advisory roles, and franchise ventures like Work Your Core—reflect a blueprint that prioritizes long-term value over quick exits.
What sets Schissler apart is his business + investment strategy: build equity, reinvest gains, avoid lifestyle inflation, and compound quietly across sectors from biotech to fitness. For readers interested in a deeper look at his career trajectory, see our detailed Matthew Schissler Biography: Career, Businesses & Financial Success Story. And to understand exactly how each income stream operates, explore How Matthew Schissler Makes Money: Business Ventures, Investments & Income Sources.
In a world of flashy billionaires, Schissler represents the realistic millionaire next door—wealth built methodically, one business and one investment at a time.